Professionals 206 Users Online

Canine Stem Cell Therapy Market

Global Market Study on Canine Stem Cell Therapy: Ongoing Clinical Trials and Focus on Advancements to Push Adoption in Veterinary Clinics

Canine Stem Cell Therapy Market Segmented By Allogeneic Stem Cells, Autologous Stem cells for Arthritis, Dysplasia, Tendonitis, Lameness

Introduction

The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Growing number of clinical trials has paved way for the rise in the adoption of canine stem cell therapy in veterinary clinics

The actual market opportunity lies in the growing preference for allogeneic stem cells over autologous stem cells. A number of stem cell therapy products for dogs are under clinical trials, which is anticipated to attract major revenues for the canine stem cell therapy market over the coming years.

Currently, VetStem in collaboration with Aratana Therapeutics is making the allogeneic stem cells to treat osteoarthritis in dogs. In 2016, the company submitted a trial data of allogeneic stem cells to the FDA as a part of a licensing application. The licensing application was submitted to FDA in order to achieve marketing approval and sales support in the U.S. The clinical trial registered over 90 dogs in the study and was controlled by placebo.

Furthermore, in May 2017, a nationwide stem cell study was conducted with dogs in the U.S. for the treatment of arthritis, for over a six-month period. This study created a lucrative opportunity for stem cell therapy treatment and a range of possibilities to confirm the efficacy of the technique for arthritis, which resulted in expanded revenue of the canine stem cell therapy market.

Lately in 2017, a study named “Stem Cell Injections for Dogs with Chronic Severe Spinal Cord Injuries” was performed on dogs with austere chronic spinal cord injuries including disc herniation or trauma. The objective of the study was to evaluate the clinical outcome of the research on these dogs after transplantation of the canine stem cells.

canine stem cell therapy market

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Agreement among leading veterinary groups for conducting operations is expected to benefit both clinics and hospitals

Growing penetration of veterinary healthcare has exponentially amplified demand for veterinaries and clinics. People seem spend more on veterinary services than on medicines. Several veterinary groups from across the world are combining their operations in order to expand their reach and secure profit in the global marketplace. In February 2017, Independent Vetcare (IVC) and Evidensia announced its intension to work as a combined entity. Evidensia marks strong presence in Northern Europe and IVC in the U.K.

The collaboration helped in establishing a dynamic network of leading clinical facilities with about 500 clinics across wight countries and benefit from shared best practice and improved purchasing power. With the augmented number of veterinary clinics and veterinarians, the adoption of canine stem cell therapy is also expected to surge in near future.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Market Taxonomy

Attribute Details

Product Type

  • Allogeneic Stem Cells
  • Autologous Stem cells
Application
  • Arthritis
  • Dysplasia
  • Tendonitis
  • Lameness
  • Others

End User

  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Research Institutes
Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Japan
  • Middle East & Africa
Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

- Companies Covered in This Report -

  • VETSTEM BIOPHARMA
  • Cell Therapy Sciences
  • Regeneus Ltd.
  • Aratana Therapeutics
  • Medivet Biologics LLC
  • Okyanos
  • Vetbiologics
  • VetMatrix
  • Magellan Stem Cells
  • ANIMAL CELL THERAPIES, INC
  • stemcellvet.co.uk
  • Others.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate